PPAR-γ and AMPK – Advantageous targets for myocardial ischemia/reperfusion therapy
Author:
Funder
American Heart Association Scientist Development Grant
American Diabetes Association Basic Sciences Grant
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference83 articles.
1. Heart disease and stroke statistics – 2010 update: a report from the American Heart Association;Lloyd-Jones;Circulation,2010
2. Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling;Khan;J Pharmacol Exp Ther,2010
3. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations;Wang;Expert Rev Cardiovasc Ther,2007
4. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo;Young;Circulation,1997
5. Pathogenesis of myocardial ischemia–reperfusion injury and rationale for therapy;Turer;Am J Cardiol,2010
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sulfide-modified nanoscale zero-valent iron as a novel therapeutic remedy for septic myocardial injury;Journal of Advanced Research;2024-01
2. Exploring the role and mechanism of hyperoside against cardiomyocyte injury in mice with myocardial infarction based on JAK2/STAT3 signaling pathway;Phytomedicine;2023-12
3. Nuciferine improves cardiac function in mice subjected to myocardial ischemia/reperfusion injury by upregulating PPAR-γ;Heliyon;2023-02
4. Metformin confers longitudinal cardiac protection by preserving mitochondrial homeostasis following myocardial ischemia/reperfusion injury;European Journal of Nuclear Medicine and Molecular Imaging;2022-11-02
5. Role of AMPK in Myocardial Ischemia-Reperfusion Injury-Induced Cell Death in the Presence and Absence of Diabetes;Oxidative Medicine and Cellular Longevity;2022-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3